Cancer Drug | ₹2,700 To ₹27,000: Why Is There A 10X Price Gap For This Cancer Drug?

A cancer drug priced at ₹2,700 to the retailer is being sold at a maximum retail price of ₹27,000 - a ten-fold difference that has raised serious questions about drug pricing in India. The Supreme Court has questioned such a massive price gap and described the practice as "broad daylight dacoity." The case raises wider questions about how cancer medicines are priced, which drugs come under price control, and the role of the National Pharmaceutical Pricing Authority (NPPA). With cancer treatment often involving significant out-of-pocket expenses, the issue has a direct impact on patients and their families. NDTV Health Editor Sneha Mordani examines where the price gap comes from and whether the pricing of life-saving cancer drugs can be justified.